A young male schizophrenic presented with neuroleptic malignant syndrome (NMS). Risperidone was the probable precipitating agent. Rigidity and elevated CPK levels poorly responded to bromocriptine, but showed good response to dantrolene. The role of specific treatment and the differential response of the symptom clusters are discussed

Gangadhar, B.N.

Venkatasubramanian, G.

Yogananda, B.H.

PubMed Central

English

Dantrolene -A new therapeutic approach to the neuroleptic malignant syndrome.

Deniker,P.(1968) Drug induced extrapyramidal syndromes.

Levenson,J.L.(1985) Neuroleptic malignant syndrome.

Mortality from neuroleptic malignant syndrome.

Neuroleptic malignant syndrome associated with olanzapine.

Neuroleptic malignant syndrome,

Neuroleptic malignant syndrome.

the neuroleptic malignant syndrome : a review and critique.

Wooten,G.F.(1981) Neuroleptic Malignant Syndrome A pathogenetic role for dopamine receptor blockade?

RISPERIDONE-INDUCED NEUROLEPTIC MALIGNANT SYNDROME : A CASE REPORT